Eric-Paul Pâques, chief executive of Grünenthal GmbH, has been appointed to the supervisory board of Proteros biostructures GmbH, a privately-owned company focusing on protein-based drug discovery. Prior to his more than 20 years at Grünenthal, Prof Pâques was head of research at Behringwerke AG in Germany. Prof Pâques received a doctorate in chemistry from the Université Catholique de Louvain in Belgium.
Proteros announced the appointment on 20 February 2014.
Copyright 2014 Evernow Publishing Ltd.